Telix Pharmaceuticals | TLX - Gewinn Vor Steuern

Aktienkurs
13.64
Täglich Wechseln
-0.31 -2.22%
Monatlich
24.00%
Jährlich
-48.68%
Q2 Prognose
12.67




Gewinn Vor Steuern Veränderung Datum
Cochlear AUD 121.1M 155.6M 2025-06
CSL USD 2.61B 1.21B 2025-12
Integral Diagnostics AUD 14.49M 47.37M 2024-06
Mayne Pharma AUD -14.7M 42.91M 2024-12
Medical Developments International AUD -149K 466K 2025-06
Mesoblast USD -54.09M 6.37M 2025-06
Neuren Pharmaceuticals AUD 9.86M 161.24M 2025-06
Pacific Edge NZD -714K 49K 2024-03
Polynovo AUD 1.96M 146K 2025-12
PYC Therapeutics AUD -12.57M 13.3M 2025-06
Ramsay Health Care AUD 103.75M 54.35M 2025-06
ResMed USD 496.15M 13.77M 2025-12
Sonic Healthcare AUD 402.01M 53.16M 2025-06